Nuvectis Pharma, Inc.

Nasdaq:NVCT

Pharmaceutical Preparations·FORT LEE, NJ

CEO

Bentsur Ron

Financials

18 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/11/26	→
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	2/25/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
2/11/26	Q1 FY2026	→
11/4/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
2/25/25	Q1 FY2025	→
11/5/24	Q4 FY2024	→
↓

News (8-K)

11 shown

Filed	Type	Description
9/25/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/13/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/9/25	Other	Other Events	→
2/6/25	Agreement	Entry into a Material Definitive Agreement	→
8/29/24	Other	Other Events	→
6/13/24	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

22 shown

Filed	Form	Description
2/13/26	S-3	S-3	→
5/9/25	424B5	424B5	→
2/6/25	424B5	424B5	→
2/4/25	424B5	424B5	→
1/3/25	S-8	S-8	→
8/9/23	S-8	S-8	→
↓

Filing History(248 filings)

TypeDateAccessionPeriodSize

EFFECT

Feb 20, 2026

9999999995-26-000644

—

1.7 KB

S-3

Feb 13, 2026

0001104659-26-015159FORM S-3

—

1.1 MB

8-K

Feb 11, 2026

0001104659-26-013049FORM 8-K

Feb 11, 2026

246.0 KB

10-K

Feb 11, 2026

0001104659-26-01304410-K

Dec 31, 2025

6.2 MB

Jan 9, 2026

0001104659-26-002501OWNERSHIP DOCUMENT

Jan 6, 2026

4.9 KB

Jan 9, 2026

0001104659-26-002500OWNERSHIP DOCUMENT

Jan 6, 2026

4.8 KB

Jan 9, 2026

0001104659-26-002497OWNERSHIP DOCUMENT

Jan 6, 2026

4.9 KB

Jan 9, 2026

0001104659-26-002489OWNERSHIP DOCUMENT

Jan 6, 2026

4.9 KB

Nov 6, 2025

0001104659-25-107423OWNERSHIP DOCUMENT

Nov 5, 2025

4.6 KB

Nov 6, 2025

0001104659-25-107422OWNERSHIP DOCUMENT

Nov 5, 2025

5.8 KB

Nov 6, 2025

0001104659-25-107418OWNERSHIP DOCUMENT

Nov 5, 2025

5.2 KB

8-K

Nov 4, 2025

0001104659-25-105953FORM 8-K

Nov 4, 2025

258.3 KB

10-Q

Nov 4, 2025

0001104659-25-10593910-Q

Sep 30, 2025

4.4 MB

Oct 31, 2025

0001104659-25-104664OWNERSHIP DOCUMENT

Sep 22, 2025

5.4 KB

Oct 31, 2025

0001104659-25-104661OWNERSHIP DOCUMENT

Sep 22, 2025

4.8 KB

Oct 29, 2025

0001104659-25-103522OWNERSHIP DOCUMENT

Oct 23, 2025

8.5 KB

8-K

Sep 25, 2025

0001104659-25-093144FORM 8-K

Sep 22, 2025

208.2 KB

10-Q

Aug 5, 2025

0001558370-25-01020310-Q

Jun 30, 2025

4.3 MB

8-K

Aug 5, 2025

0001104659-25-073967FORM 8-K

Aug 5, 2025

259.3 KB

Jun 24, 2025

0001104659-25-062168OWNERSHIP DOCUMENT

Jun 20, 2025

5.3 KB

Jun 20, 2025

0001104659-25-060965OWNERSHIP DOCUMENT

Jun 17, 2025

7.0 KB

8-K

Jun 13, 2025

0001104659-25-059435FORM 8-K

Jun 12, 2025

190.3 KB

Jun 12, 2025

0001104659-25-058919OWNERSHIP DOCUMENT

Jun 12, 2025

4.8 KB

Jun 12, 2025

0001104659-25-058916OWNERSHIP DOCUMENT

Jun 12, 2025

4.8 KB

Jun 12, 2025

0001104659-25-058915OWNERSHIP DOCUMENT

Jun 12, 2025

4.8 KB

25 filings shown

Filed	Form	Description
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
4/28/23	DEF 14A	DEF 14A	→

Nuvectis Pharma, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(248 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
1/9/26	4	OWNERSHIP DOCUMENT	→
11/6/25	4	OWNERSHIP DOCUMENT	→
11/6/25	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
2/20/26	EFFECT	EFFECT	→
3/29/23	EFFECT	EFFECT	→
8/24/22	EFFECT	EFFECT	→
8/10/22	D	D	→
2/4/22	SEC STAFF LETTER	SEC STAFF LETTER	→
2/4/22	EFFECT	EFFECT	→
↓